These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2119523

  • 1. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor.
    Veenstra J, Kluft C, Ockhuizen TH, vd Pol H, Wedel M, Schaafsma G.
    Thromb Haemost; 1990 Jun 28; 63(3):345-8. PubMed ID: 2119523
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers.
    Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P.
    Eur J Clin Nutr; 1996 Apr 28; 50(4):209-13. PubMed ID: 8730606
    [Abstract] [Full Text] [Related]

  • 4. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regular alcohol intake and fibrinolysis.
    van Golde PM, Hart HCh, Kraaijenhagen RJ, Bouma BN, van de Wiel A.
    Neth J Med; 2002 Aug 08; 60(7):285-8. PubMed ID: 12430575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 08; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA, Fernández Diaz FJ, Rocha E.
    Thromb Haemost; 1988 Jun 16; 59(3):451-4. PubMed ID: 3142082
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Tissue plasminogen activator, its inhibitor and other parameters of fibrinolysis in blood of patients operated for mild hypertrophy of the prostate].
    Iwan-Zietek I, Zietek Z, Kotschy M, Rość D, Tyloch F, Cwiklińska-Jurkowska M.
    Pol Tyg Lek; 1988 Jun 16; 47(49-50):1096-7. PubMed ID: 1284828
    [Abstract] [Full Text] [Related]

  • 12. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Jun 16; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 13. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M, Miyashita C.
    Klin Wochenschr; 1988 Jun 16; 66 Suppl 12():62-7. PubMed ID: 3126347
    [Abstract] [Full Text] [Related]

  • 14. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C, Angles-Cano E.
    Ann Biol Clin (Paris); 1989 Jun 16; 47(5):269-74. PubMed ID: 2500878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M, Philips M, Thorsen S, Selmer J, Zeuthen J.
    Thromb Haemost; 1987 Oct 28; 58(3):872-8. PubMed ID: 3124286
    [Abstract] [Full Text] [Related]

  • 17. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
    Hach-Wunderle V, Scharrer I.
    Vasa Suppl; 1993 Oct 28; 39():5-10. PubMed ID: 8322122
    [Abstract] [Full Text] [Related]

  • 18. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep 28; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 19. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 28; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 20. [Effect of molsidomine on fibrinolytic activity: a double-blind, randomized study].
    Darius H, Grodzinska L, Hafner G, Meyer J.
    Z Kardiol; 1991 Aug 28; 80 Suppl 5():47-50. PubMed ID: 1776335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.